Earth Science Tech (ETST) details move to SIC 2834 pharmaceutical classification

Rhea-AI Filing Summary

Earth Science Tech, Inc. filed a current report to disclose that it has issued a press release about an industry classification update. On January 6, 2026, the company announced a directive industry classification update to Standard Industrial Classification (SIC) code 2834, which is used for pharmaceutical-related entities. The disclosure notes that the company has formally identified as a pharmaceutical entity since 2022. The press release describing this classification update is included as an exhibit to the report.

false 0001538495 0001538495 2026-01-06 2026-01-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 6, 2026

Commission File No. 000-55000

EARTH SCIENCE TECH, INC.

(Exact name of registrant as specified in its charter)

florida		45-4267181
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

8950 SW 74^th CT

Suite 1401

Miami, FL 33156, USA

(Address of principal executive offices, zip code)

(305) 724-5684

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(g) of the Act:

Title of Each Class		Trading Symbol		Name of each exchange on which registered
Common Stock $0.001 par value		ETST		Over the Counter Bulletin Board

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

On January 6, 2026, Earth Science Tech, Inc., a Florida corporation (the “Company”) issued a press release (the “Release”), issuing a directive industry classification update to SIC 2834; formally identifies as pharmaceutical entity since 2022.

A copy of the Release issued by the Company on January 6, 2026, announcing the engagement is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits – The following exhibits are filed as part of this report:

Exhibit No.		Description
99.1		Press release issued by the registrant on January 6, 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	EARTH SCIENCE TECH, INC.
Dated: January 6, 2026	By:	/s/ Giorgio R. Saumat
		Giorgio R. Saumat
	Its:	CEO and Chairman of the Board

FAQ

What did Earth Science Tech, Inc. (ETST) announce in its latest 8-K filing?

Earth Science Tech, Inc. reported that it issued a press release announcing a directive industry classification update to SIC 2834 and stated that it has formally identified as a pharmaceutical entity since 2022.

How is Earth Science Tech, Inc. (ETST) now classified by industry?

The company disclosed an industry classification update to SIC 2834, which corresponds to a pharmaceutical-related classification, and indicated it has formally identified as a pharmaceutical entity since 2022.

When did Earth Science Tech, Inc. issue the press release about the SIC 2834 update?

The company issued the press release on January 6, 2026, and referenced it in the current report filed on the same date.

Where can investors find details of Earth Science Tech, Inc.'s industry classification update?

The details are contained in a press release that is attached to the report as Exhibit 99.1 and incorporated by reference.

Does the 8-K filing from Earth Science Tech, Inc. include any financial results or earnings data?

No, this report focuses on an industry classification update to SIC 2834 and references a related press release; it does not present financial or earnings data.

What exhibits are attached to Earth Science Tech, Inc.'s January 6, 2026 report?

The report includes Exhibit 99.1, a press release issued on January 6, 2026, and an Exhibit 104 cover page interactive data file embedded within the Inline XBRL document.